Protocol
11-194
Full Title
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
Purpose
Cancer chemotherapy now includes an increasing number of medications that are taken orally (by mouth). However, some studies have found that many patients do not take the drugs as prescribed, and healthcare professionals are eager to know why.
The purpose of this study is to determine what makes it easier for patients to take oral chemotherapy (such as tablets and capsules) and what makes it more difficult. Participants will complete a short questionnaire about factors that influence their ability to take oral chemotherapy; some will have a short interview with a nurse.
Investigator
Ginex, Pamela, RN, EDD
Co-Investigators
Thom, Bridgette, MA
Eligibility
Participants in this study will include patients age 21 and older who are taking capecitabine for breast cancer or gastrointestinal cancers (colorectal, esophageal, stomach, or pancreatic cancer). Participants must be able to understand written and spoken English.
For more information about this study, please contact research nurse Pamela Ginex, RN, at 646-449-1077.
Disease(s)
Breast Cancer
Colorectal Cancer
Colorectal Cancer: Colon Cancer
Hepatobiliary: Pancreatic Cancer
Upper Gastrointestinal: Esophageal Cancer
Upper Gastrointestinal: Gastric Cancer
Upper Gastrointestinal: Pancreatic Cancer
Locations
ClinicalTrials.gov
Related Diseases
